Sabby Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Sabby Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-503	Closed	-$802K	–	319
2016 Q4	$802K	Sell	503 -744	-60%	-$12K	0.05%	160
2016 Q3	$2.08M	Sell	1,247 -143	-10%	-$1.93K	0.08%	130
2016 Q2	$1.55M	Buy	+1,390	New	+$13.5K	0.08%	126
2015 Q2	–	Sell	-2,019	Closed	-$1.88M	–	360
2015 Q1	$1.88M	Buy	2,019 +1,519	+304%	+$17.2K	0.08%	150
2014 Q4	$716	Sell	500 -2,816	-85%	-$33.3K	0.02%	175
2014 Q3	$2K	Buy	3,316 +1,616	+95%	+$21.2K	0.08%	108
2014 Q2	$2.75M	Buy	+1,700	New	+$22.6K	0.12%	84
2013 Q4	–	Sell	-1,827	Closed	-$2M	–	246
2013 Q3	$2M	Buy	+1,827	New	+$19.5K	0.13%	86

Other funds holding VNDA

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabby Management's VNDA Position: Q2 2015 in Review

Sabby Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2015, closing a stake of 113,165 shares — an estimated $1.05M sold.

Sabby Management first reported a position in VNDA in Q2 2013 and held it in 5 quarters. The position peaked at $2.1M in Q2 2014. 109 funds tracked by Wall St. Rank hold VNDA as of Q2 2015.

Sabby Management reported no remaining Vanda Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Sabby Management sold 113,165 Vanda Pharmaceuticals shares in Q2 2015, an estimated $1.05M.
Sabby Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Sabby Management's Vanda Pharmaceuticals position peaked at $2.1M in Q2 2014.
109 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2015.

Based on Sabby Management's 13F filing for Q2 2015, filed 14 Aug 2015.